BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 30231925)

  • 1. The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.
    Bosma EK; van Noorden CJF; Schlingemann RO; Klaassen I
    Fluids Barriers CNS; 2018 Sep; 15(1):24. PubMed ID: 30231925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
    Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
    Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.
    van der Wijk AE; Canning P; van Heijningen RP; Vogels IMC; van Noorden CJF; Klaassen I; Schlingemann RO
    Acta Ophthalmol; 2019 Mar; 97(2):214-224. PubMed ID: 30168271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.
    Klaassen I; Van Noorden CJ; Schlingemann RO
    Prog Retin Eye Res; 2013 May; 34():19-48. PubMed ID: 23416119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-PLVAP antibody suppresses laser-induced choroidal neovascularization in monkeys.
    Nakagami Y; Hatano E; Chayama Y; Inoue T
    Eur J Pharmacol; 2019 Jul; 854():240-246. PubMed ID: 31026444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of PLVAP in endothelial cells.
    Denzer L; Muranyi W; Schroten H; Schwerk C
    Cell Tissue Res; 2023 May; 392(2):393-412. PubMed ID: 36781482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression.
    D'Amico AG; Maugeri G; Rasà DM; La Cognata V; Saccone S; Federico C; Cavallaro S; D'Agata V
    J Cell Physiol; 2018 Feb; 233(2):1120-1128. PubMed ID: 28436035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine promotes blood retinal barrier damage in a model of human diabetic macular edema.
    Maugeri G; D'Amico AG; Rasà DM; La Cognata V; Saccone S; Federico C; Cavallaro S; D'Agata V
    Toxicol In Vitro; 2017 Oct; 44():182-189. PubMed ID: 28689815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Cell-Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature.
    Zhang C; Lai MB; Pedler MG; Johnson V; Adams RH; Petrash JM; Chen Z; Junge HJ
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2691-2705. PubMed ID: 30354230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1α/VEGF pathway.
    Li J; Lu X; Wei L; Ye D; Lin J; Tang X; Cui K; Yu S; Xu Y; Liang X
    Inflamm Res; 2022 Jan; 71(1):69-79. PubMed ID: 34773469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective factors in diabetic retinopathy: focus on blood-retinal barrier.
    Zhang C; Wang H; Nie J; Wang F
    Discov Med; 2014 Sep; 18(98):105-12. PubMed ID: 25227751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes.
    Wisniewska-Kruk J; Hoeben KA; Vogels IM; Gaillard PJ; Van Noorden CJ; Schlingemann RO; Klaassen I
    Exp Eye Res; 2012 Mar; 96(1):181-90. PubMed ID: 22200486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
    Edelman JL; Lutz D; Castro MR
    Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema.
    Noma H; Yasuda K; Shimura M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VIP Family Members Prevent Outer Blood Retinal Barrier Damage in a Model of Diabetic Macular Edema.
    Maugeri G; D'Amico AG; Gagliano C; Saccone S; Federico C; Cavallaro S; D'Agata V
    J Cell Physiol; 2017 May; 232(5):1079-1085. PubMed ID: 27486932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmalemma vesicle-associated protein: A crucial component of vascular homeostasis.
    Guo L; Zhang H; Hou Y; Wei T; Liu J
    Exp Ther Med; 2016 Sep; 12(3):1639-1644. PubMed ID: 27602081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel potential mechanisms for diabetic macular edema: leveraging new investigational approaches.
    Gardner TW; Antonetti DA
    Curr Diab Rep; 2008 Aug; 8(4):263-9. PubMed ID: 18631437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of inflammation in diabetic eye disease.
    Mesquida M; Drawnel F; Fauser S
    Semin Immunopathol; 2019 Jul; 41(4):427-445. PubMed ID: 31175392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertonic saline alleviates experimentally induced cerebral oedema through suppression of vascular endothelial growth factor and its receptor VEGFR2 expression in astrocytes.
    Huang L; Cao W; Deng Y; Zhu G; Han Y; Zeng H
    BMC Neurosci; 2016 Oct; 17(1):64. PubMed ID: 27733124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.